A research peptide’s storage instructions should answer more than “fridge or freezer?” They should explain which conditions apply to the supplied material, how long those conditions are supported and what changes after the container is opened or the peptide is prepared for an experiment.
There is no single storage temperature or shelf life that applies to every research peptide. The useful starting point is the specification for the particular product and formulation, supported by relevant stability information.
For laboratories, the aim is to preserve material that remains suitable for its intended work—and retain enough information to investigate its history if results change.
Start with the instructions for the actual product
Check the container label, current product information and batch documentation together.
Confirm that the instructions apply to the same chemical form and presentation you received. A lyophilised powder, a supplied solution and a solution prepared in the laboratory should not automatically inherit the same storage period.
OECD’s Good In Vitro Method Practices guidance recommends following the manufacturer’s storage specifications in the certificate of analysis or product information. It also recommends defining reagent labelling and recording relevant preparation information.[1]
If the label and website disagree, ask the supplier to reconcile them in writing. Choosing whichever instruction gives the longest storage period leaves an uncertainty that can later affect interpretation of the experiment.
How to read common storage statements
| Example wording | What to establish before relying on it |
|---|---|
| “Store at 2–8°C” | Does this apply to unopened stock, opened stock, or both? What supports any permitted excursions? |
| “Store at −20°C” | What operating range is intended, and does the instruction apply to the supplied formulation? |
| “Do not freeze” | Keep this restriction in the laboratory procedure; colder is not automatically an acceptable substitute. |
| “Protect from light” | Which packaging and handling conditions maintain that protection? |
| “Keep dry” | What measures are required during storage and opening to control moisture exposure? |
| “Use within X days after opening” | What event starts the period, and which conditions must be maintained during it? |
These are illustrative label statements, not recommended conditions for an unspecified peptide.
For the wider purchasing checks, see our guide to what to check before buying research peptides online.
Shelf life, expiry date and retest date mean different things
These terms are related, but they should not be used interchangeably.
- Shelf life describes a supported storage period under stated conditions.
- Expiry date identifies the end of the assigned period for use under those conditions.
- Retest date identifies when the material should be reassessed to determine whether it remains suitable.
OECD’s guidance for test items used in GLP studies explicitly distinguishes expiry from retest: reaching a retest date calls for re-examination, rather than automatically establishing either acceptability or failure.[2]
A laboratory should not simply change a date because a vial looks unchanged. Any extension needs a documented basis and an appropriate decision under the laboratory’s procedures.
Also establish whether a date applies only to the original unopened container. A preparation made later may need its own supported use period.
Why peptide stability is product-specific
Temperature is only one part of the storage question.
Bachem’s handling guidance identifies differences associated with peptide chemistry and warns that some sequences have limited stability. It also describes the sensitivity of lyophilised material to atmospheric moisture and the potential for chemical degradation in solution.[3]
That means a storage statement for one peptide cannot reliably be transferred to another merely because both are sold as research materials.
Likewise, “stable” needs a defined meaning. Ask which properties were evaluated: chemical integrity, recoverable amount, concentration, activity where relevant, or another characteristic needed by the assay.
A report showing acceptable purity at one point in time does not answer every one of those questions.
Shipping conditions and storage conditions can differ
A product labelled for refrigerated or frozen storage does not necessarily require the identical conditions for every permitted transport period.
For example, Bachem describes ambient shipping for products discussed in its peptide handling guide while giving different recommendations for longer storage.[3] That is a supplier-specific example, not permission to ship every peptide at ambient temperature.
The buyer should ask whether the actual dispatch arrangement is supported for the product, expected journey and delivery circumstances.
A cold pack on arrival cannot reconstruct the complete temperature history. Equally, an unfrozen pack is not sufficient evidence, on its own, that the product has failed.
A practical receipt checklist
On arrival:
- Match the product and lot to the order.
- Record receipt time and inspect the container and seals.
- Retrieve transport monitoring data where supplied.
- Compare the delivery with the agreed acceptance conditions.
- Record discrepancies and place the material under the specified storage conditions promptly.
OECD’s GLP test-item guidance calls for a documented receipt assessment, including the condition of the material and container and transport conditions where monitored.[2] Outside that GLP setting, this is a useful model for designing a proportionate laboratory check.
What to do after a temperature excursion
A temperature excursion is a departure from the applicable permitted conditions. A freezer alarm, delayed delivery or prolonged time on a bench can trigger a review, but the temperature and duration need to be established as far as possible.
A practical response is to:
- Prevent further unapproved use. Flag the affected containers while the laboratory assesses them.
- Limit further exposure. Restore the specified conditions where appropriate and record the action.
- Preserve the evidence. Save logger records, times, packaging observations and relevant handling history.
- Request a product-specific assessment. Give the supplier the lot, formulation and available exposure details.
- Record the decision. Document the basis for acceptance, further testing, restricted use or rejection.
Returning a product to its specified temperature does not demonstrate that any earlier change has been reversed. Conversely, an excursion alone does not quantify the damage.
If the supplier cannot support an assessment, the responsible laboratory team must decide what evidence is needed before relying on the material.
Example: the missing history matters
Imagine a research solution has a specified storage range of 2–8°C. It arrives with a logger showing 14°C for approximately three hours.
The useful question is whether the evidence for that formulation and container supports the recorded exposure. The assessment may also need to consider previous excursions and whether the product was opened.
Now imagine the same parcel arrives without a logger and its outer packaging feels warm. That observation is worth recording, but it cannot establish that the solution spent three hours at 14°C.
This is a fictional example. It does not establish an acceptable excursion for any peptide or Coridion Sciences product.
Monitor the conditions that matter to the material
A refrigerator display provides limited information about the history of a particular stored container.
Monitoring should be designed around the material, storage location and decisions the laboratory needs to make. Consider sensor placement, appropriate calibration, recording intervals and who responds when conditions move outside the applicable limits.
NIST research on refrigerated vaccine monitoring demonstrates why the measurement setup matters: the investigators distinguished measurements representative of stored liquid products from measurements of rapidly changing air temperature.[4]
That study concerns vaccines, not peptide shelf lives. Its broader measurement lesson is relevant: understand what the sensor is measuring before using its readings to make a product decision.
For peptide storage, the monitoring arrangement should suit the actual containers and conditions, including the relevant temperature range. A logger does not independently establish whether the peptide remains acceptable.
Moisture, opening and repeated handling also matter
Storage can be compromised even when the refrigerator or freezer performs correctly.
Bachem notes that peptide lyophilisates can absorb moisture, which can reduce peptide content and affect stability. Its handling guidance recommends allowing the closed container to reach ambient temperature in a desiccator before opening to weigh material.[3]
Apply the relevant supplier procedure to the actual product. Do not convert guidance for a dry material into an instruction to repeatedly warm every liquid formulation.
Once material has been opened or prepared, keep its subsequent handling identifiable. A stock repeatedly accessed over several weeks has a different history from an unopened container beside it.
Freeze–thaw cycles need evidence
Dividing a suitable solution into aliquots can reduce repeated opening and thawing of the same stock.
However, aliquoting does not create a new guaranteed shelf life. OECD’s in vitro guidance recommends establishing how many freeze–thaw cycles a reagent can tolerate and verifying aliquot stability in the laboratory using the method.[1]
Follow any “do not freeze” instruction. Where freezing is permitted, the relevant procedure should address the formulation, containers and subsequent use.
Changing containers can change recovery
Transferring material into another tube may be convenient, but container selection deserves attention.
Kraut and colleagues compared storage of proteomics peptide samples over 28 days in standard plastic, glass and low-adsorption plastic tubes. Under their experimental conditions, recovery differed between the containers, with low-adsorption plastic giving the best overall recovery. Peptides with poor recovery were mainly hydrophobic.[5]
This finding does not establish a universal preferred container for every research peptide. It does show why an existing storage claim should not automatically be extended to an unrelated container.
If the laboratory changes the container, concentration or formulation, consider whether the evidence still represents the material being used.
A COA and a stability study answer different questions
A certificate of analysis usually reports specified tests on material represented by the certificate. Its dates and results are valuable, but an initial result alone does not demonstrate acceptable performance throughout storage.
A useful stability assessment connects:
- The material and formulation examined.
- The container and conditions used.
- The time points evaluated.
- Tests capable of detecting relevant changes.
- Defined acceptance criteria.
ICH Q1A(R2), a pharmaceutical stability guideline, describes testing relevant attributes over time using stability-indicating methods and suitable packaging.[6] Here it provides an example of the evidence needed to evaluate change; it is not presented as a certification requirement for all research suppliers.
For help interpreting a batch report, read how to read a peptide certificate of analysis.
Remember that chromatographic purity and peptide content are distinct measurements.[7] Our explanation of what 99% peptide purity actually means covers why a high purity figure should not be treated as a complete statement of product condition.
Keep a useful storage history
A storage record should help a researcher identify what happened to the material.
Alongside the supplier’s product and lot identifiers, useful entries include the laboratory container ID, storage location, applicable instructions, opening or preparation dates, relevant transfers and documented deviations.
Connect each preparation to its source. If stock is divided, the new labels should preserve that connection rather than leave the laboratory with several indistinguishable tubes.
OECD’s in vitro guidance includes recording relevant supplier, lot and preparation details.[1] A practical extension is to make the history retrievable from the experimental record, so an investigator can identify which material was actually used.
For supplier documentation questions, use our research peptide supplier checklist.
Questions to resolve before ordering
Before buying material for a planned project, ask the supplier:
- Which storage instructions apply to the exact supplied form?
- What evidence supports the stated period?
- Are unopened, opened and prepared-product instructions different?
- Is freezing permitted, and are there relevant handling limits?
- What transport conditions are supported?
- Who can assess a reported excursion or discrepancy?
The answers should be specific enough to use in the laboratory’s procedures. “Keep cool” or “stable for months” leaves important details unresolved.
When assessing Coridion Sciences research peptides, request the relevant product information before purchase and retain the batch documents with the material’s records.
Good storage practice connects a supported instruction to an observed history. That gives the laboratory a defensible basis for deciding whether a peptide remains suitable for its work.
Sources
- OECD (2018) — Guidance Document on Good In Vitro Method Practices (GIVIMP). Chapter 4, section 4.2: manufacturer storage specifications, reagent records, aliquoting and freeze–thaw stability. Read the source.
- OECD (2018) — Management, Characterisation and Use of Test Items used in GLP studies. Advisory Document No. 19; paragraphs 14–15 and 21–22 cover expiry/retest terminology and transport/receipt assessment. Read the source.
- Bachem — Handling and Storage Guidelines for Peptides. Manufacturer guidance on sequence-dependent stability, moisture, handling and shipping. Read the source.
- Chojnacky MJ (2012) — Data Logger Thermometers for Vaccine Temperature Monitoring. NISTIR 7899. Used for its findings on representative temperature measurement, not peptide stability limits. Read the source.
- Kraut A et al. (2009). Peptide storage: are you getting the best return on your investment? Defining optimal storage conditions for proteomics samples. Journal of Proteome Research, 8(7):3778–3785. DOI: 10.1021/pr900095u. Original research; the summary here is based on the published abstract. Read the abstract.
- ICH (2003) — Q1A(R2): Stability Testing of New Drug Substances and Products. Particularly sections 2.1.4–2.1.6 and 2.2.4–2.2.7. Cited as a pharmaceutical example of stability-study principles. Read the source.
- Bachem — Quality Control of Amino Acids & Peptides: A Guide. Distinction between chromatographic purity and peptide content. Read the source.
Sources reviewed on 9 October 2026. The label examples, excursion scenario and suggested workflow are editorial illustrations, not product-specific stability data. This article concerns laboratory research materials.